The global polymer emulsions market is projected to grow from $37 billion in 2025 to $51.4 billion by 2032, at a CAGR of 4.8%. Growth is fueled by rising demand for eco-friendly water-based products, ongoing construction and infrastructure investments, and increased use of high-performance coatings and adhesives. Asia-Pacific leads the market with 43% revenue share and the fastest growth rate of 5.9%, driven by industrialization and urban development in countries like China and India. Acrylic emulsions dominate polymer types, while paints and coatings hold the largest application share, with building and construction as the top end-use sector.
The global polymer emulsions market is forecasted to reach $51.4 billion by 2032 with a CAGR of 4.8%. For readers following Basic Materials stocks on Pluang, as of Oct 16, 2026 17:01 WIB, 53 of 83 stocks rose while 24 fell. Notable movers include Cleveland-Cliffs Inc. at USD 12.29 (+1.11%), AngloGold Ashanti Limited at USD 92.55 (+1.07%), and ArcelorMittal SA at USD 64.27 (+1.05%).
NeOnc Technologies reported early clinical improvement in a critically ill three-year-old boy with an aggressive brain tumor treated with investigational intranasal NEO100 under compassionate use in Abu Dhabi. The child is now breathing independently...
TransUnion's Branded Call Display, a solution that helps consumers identify legitimate callers and avoid robocall fraud, has been named one of TIME's Best Inventions of 2026 in the Connectivity & Communication category. The technology displays a busi...
La Rosa Holdings Corp. will change its name to Stratum Holdings Corp. on October 19, 2026, reflecting its shift from real estate services to an AI infrastructure company specializing in GPU leasing and high-performance computing. The company recently...
ASUS has released the ProArt P16 and P14 laptops in Canada, powered by NVIDIA RTX Spark technology. These laptops feature up to 128GB of unified memory and advanced AI capabilities designed for creators, AI developers, and workflow builders, enabling...
OXB, a global cell and gene therapy CDMO, has appointed Dr Joachim Kreuzburg as an Independent Non-Executive Director effective November 23, 2026. Dr Kreuzburg brings over 20 years of leadership in life sciences, notably transforming Sartorius AG int...
